The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.
October 06, 2020
Rapid Heart Function Analysis by Avalon-H90 Device May Identify Myocarditis In COVID-19 Patients
October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc. using a superconducting quantum…
Read More
The U.S. Food and Drug Administration (FDA) cleared the Biosense Webster ThermoCool SmartTouch SF Ablation Catheter for the treatment of persistent atrial fibrillation (persistent AF).
October 06, 2020
FDA Clears Biosense Webster ThermoCool SmartTouch SF Ablation Catheter for the Treatment of Persistent Atrial Fibrillation
October 6, 2020 – The U.S. Food and Drug Administration (FDA) cleared the Biosense Webster ThermoCool SmartTouch SF…
Read More
Chest X-ray of a congestive heart failure patient, showing fluid in the lower portions of the lungs and an enlarged heart. Getty Images
October 05, 2020
ACC and Novartis Collaborate to Optimize Heart Failure Care With TRANSFORM Study
October 5, 2020 — The American College of Cardiology (ACC) says heart failure (HF) is a cardiovascular epidemic. In…
Read More
The Latest Vascular Interventional Clinical Data Presented at VIVA 2020 late-breaking sessions
October 05, 2020
The Latest Vascular Interventional Clinical Data Presented at VIVA 2020
October 5, 2020 — The Vascular Interventional Advances (VIVA) virtual conference will feature 10 late-breaking clinical…
Read More
Very ill COVID-19 patients have a high rate of in-hospital sudden cardiac arrest and a very low survival rate.
October 02, 2020
Cardiac Arrest With Poor Survival Common in Sickest COVID-19 Patients
October 2, 2020 — Even when a sudden cardiac arrest happens inside a top hospital, where a code blue team is readily…
Read More
The Cardiac Dimensions Carillon Mitral Contour System, a transcatheter device used to treat functional mitral regurgitation (FMR) in patients with heart failure.
October 02, 2020
Cardiac Dimensions Announces $17.5 Million in Financing to Accelerate Sales Expansion of The Carillon Mitral Contour System
October 2, 2020 — Cardiac Dimensions announced the company has closed a $17.5 million Series C financing that will be…
Read More
The new cardiac hybrid operating room (OR) at London Health Sciences Centre (LHSC) in London, Ontario, Canada, represents a new frontier in cardiac surgery. The customized OR features a Siemens Artis Pheno angiogray system with  3-D imaging capability with an integrated OR table that together improve workflow, increase efficiency and ensure a high-level of infection control.
October 02, 2020
Intelligent Hybrid Operating Room Help Redefine Cardiac Care at London Health Sciences Centre
October 2, 2020 — The new cardiac hybrid operating room (OR) at London Health Sciences Centre (LHSC) in London, Ontario…
Read More
The FDA granted 510(k) clearance for the SentiAR CommandEP system, the first holographic guidance system to be used during an invasive electrophysiology (EP) lab cardiac procedures. The system allows electrophysiologists to visualize 3-D electro-anatomic models in real-time, via a wearable headset and offer a truly handsfree control interface providing superior visualization, allowing them to navigate accurately within the heart during a cardiac ablation procedure.
October 01, 2020
FDA Clears First Holographic Cardiac Ablation Guidance System
October 1, 2020 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the SentiAR CommandEP system…
Read More
The FDA has cleared a new indication for the Medtronic Resolute Onyx Drug Eluting Stent, making it the first DES that only required one month of dual antiplatelet therapy (DAPT) in patients who are considered high risk for bleeding complications.
October 01, 2020
Medtronic Resolute Onyx Drug Eluting Stent First to Receive One-Month DAPT Indication
October 1, 2020 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual-…
Read More
The researchers developed an ultra thin monolithic OCT endoscope that overcomes the limitations of current, larger OCT catheters by using 3-D printed components.
October 01, 2020
World’s Smallest Intravascular OCT Imaging Device Created Using 3-D Printing
October 1, 2020 — A team of researchers led by the University of Adelaide and University of Stuttgart has used 3-D…
Read More
The two top DAIC stories in September included the use of point-of-care ultrasound (POCUS) to perform echocardiograms of COVID-19 patients rather than wheeling in larger systems that are more difficult to sanitize. The second top story was on a new trial for Abbott's bioresorbable stent for below-the-knee (BTK) peripheral artery disease lesions. This is a resumption of bioresorbable stent clinical research since the Absorb stent was taken off the market in 2017.
Dave Fornell, Editor
October 01, 2020
Most Popular Cardiology Technology Content in September 2020
October 1, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)…
Read More
Cardiac monitoring devices range from (left to right) the 12-lead ECG, Holter monitor, patch with snap fasteners, and patch with integrated electronics.
September 30, 2020
Flexible Electronics for Wearable Cardiac Monitoring Technologies
September 30, 2020 — In today’s digital age, focus on digital health and the quantified self have led to the rapid rise…
Read More
FDA Clears Second-Generation AcQMap 3D EP Imaging and Mapping Catheter
September 29, 2020
FDA Clears Second-Generation AcQMap 3D EP Imaging and Mapping Catheter
September 29, 2020 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the second-generation of…
Read More
September 29, 2020
ECMO Support Found Effective in Sickest of COVID-19 Patients
September 29, 2020 –  Extracorporeal membrane oxygenation (ECMO) support saved lives in past epidemics of lung-damaging…
Read More
The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.
Joe Fornadel, J.D., and Wes Moran, J.D.
September 29, 2020
Recent Developments in Artificial Intelligence and Accompanying Liability Risks
The number of Federal Drug Administration (FDA)-approved AI-based algorithms is significant and has grown at a steady…
Read More
Boston Scientific launched the Acurate neo2 transcatheter aortic valve replacement (TAVR) system in Europe. This next-generation transcatheter aortic valve implantation (TAVI) technology is a new platform designed with a number of features to improve upon the clinical performance of the original Acurate neo platform. Compared to the previous generation device, the Acurate neo2 valve system also has an expanded indication for patients with aortic stenosis. #TAVR #TAVI
September 29, 2020
Boston Scientific Launches Acurate neo2 Transcatheter Aortic Valve System in Europe
September 29, 2020 — Boston Scientific launched the Acurate neo2 transcatheter aortic valve replacement (TAVR) system…
Read More
hort-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients with COVID-19 (SARS-CoV-2) who are risk assessed prior to receiving the drug. That is the finding of research published today in EP Europace, a journal of the European Society of Cardiology (ESC). #COVID19 #SARSCoV2 #hydroxychloroquine
September 25, 2020
Short-term Hydroxychloroquine Use in COVID-19 Patients Does Not Cause Lethal Arrhythmias if Screened
September 25, 2020 — Short-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients…
Read More
The VitalPatch RTM biosensor is being used in the TELESTAR-TAVR clinical study (Deployment of Telemedicine for Symptom Tracking And Decrease Readmission Rate in TAVR Patients). It will evaluate patients who undergo a transcatheter aortic valve replacement (TAVR) and monitor them following the procedure utilizing the latest technology from VitalConnect, VistaSolution LIVE. 
September 25, 2020
VitalConnect Announces Initiation of TELESTAR-TAVR Clinical Study
September 25, 2020 — Remote and in-hospital wearable biosensor technology company VitalConnect Inc. has started the…
Read More
Philips introduced the QuickClear Mechanical Thrombectomy System. It is a simple thrombectomy solution provides physicians with an all-in-one, single-use aspiration catheter and pump system.
September 25, 2020
Philips Introduces QuickClear Mechanical Thrombectomy System for Blood Clot Removal
September 25, 2020 — Philips Healthcare launched its QuickClear mechanical thrombectomy system. The compact, single-use…
Read More
EchoGo Pro automates cardiac ultrasound measurements for heart functions, but also empower physicians to predict the occurrence of coronary artery disease (CAD).
September 25, 2020
Ultromics Earns Frost & Sullivan Innovation Award for Pioneering AI-based Cardiac Echo Software
September 25, 2020 — Based on its recent analysis of the global artificial intelligence (AI)-based echocardiography…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now